Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Símbolo de cotizaciónGELS
Nombre de la empresaGelteq Ltd
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Nathan Jacob Givoni
Número de empleados7
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 29
DirecciónLevel 4
CiudadMELBOURNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísAustralia
Código postal3205
Teléfono61390873990
Sitio Webhttps://www.gelteq.com
Símbolo de cotizaciónGELS
Fecha de salida a bolsaOct 29, 2024
Director ejecutivoMr. Nathan Jacob Givoni
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos